A legal notice has been sent to every hospital, clinic and health center in the country seeking adequate antivenom supply to prevent the death of Russell's Viper snake bite. At the same time, the government has been asked to take steps within the next seven days to produce skilled doctors and environmentally friendly vaccines within the country.

Supreme Court lawyer Bahauddin Al Imran sent the notice to the government concerned on Tuesday (June 25) in the public interest.

According to the notice, recently panic has spread in several districts of the country about Russell's Viper snake. However, due to social media Facebook, the countrymen are expressing concern about the issue. Many people are preaching that people die quickly if they bite the poisonous snake. The situation has reached such a point that many people are campaigning to kill Russell's Viper snake. Russell's viper breeds very quickly. As a result, there is widespread propaganda that the abundance of this snake in rural areas will create a threat to humans.

As a result, there is a need to widely publicize the opinions of experts on this issue. According to health experts, an ingredient that is effective against venom or can inactivate the toxin is called an antivenom. When injected with antivenom quickly after a snake bite or bite, antivenom antibodies neutralize the venom. As a result, the life or organs of the infected person are saved.

'Within seven days of receiving the notice, it was requested to preserve adequate antivenom vaccines in hospitals, clinics and healthcare centers across the country, provide advanced training to the doctors providing the vaccine as soon as possible, and take appropriate measures to produce snake venom vaccine,' the notice said. Otherwise, a writ will be filed in the High Court seeking necessary remedy in this regard.

The notice was sent to the Public Security Division secretary of the Home Ministry, the secretary of the Health Services Division of the Health Ministry, the director general of the Directorate General of Health Services and the director general of the Directorate General of Drug Administration.